← Open Payments lookup

LAUREN ELSENER: Open Payments

NPI 1457590002 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$3,335 in 194 payments from 23 companies in 2025. Trend: 2023 $3,236 · 2024 $3,255 · 2025 $3,335

Food & beverage: $3,205Education: $131
CompanyPaymentsAmount
GENZYME CORPORATION13$305
Botanix SB Inc16$280
ABBVIE INC.22$275
Janssen Biotech, Inc.12$241
UCB, Inc.10$220
REVANCE THERAPEUTICS, INC.4$206
Regeneron Healthcare Solutions, Inc.13$204
Galderma Laboratories, L.P.17$194
SUN PHARMACEUTICAL INDUSTRIES INC.5$187
Arcutis Biotherapeutics, Inc.21$161

Products named: DUPIXENT, SOFDRA, TREMFYA, Bimzelx, DAXXIFY, SKYRIZI, NEMLUVIO, Zoryve.

Industry payments across TX — which companies pay providers there.